These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cervical pessary to reduce preterm birth <34 weeks of gestation after an episode of preterm labor and a short cervix: a randomized controlled trial. Pratcorona L; Goya M; Merced C; Rodó C; Llurba E; Higueras T; Cabero L; Carreras E; Am J Obstet Gynecol; 2018 Jul; 219(1):99.e1-99.e16. PubMed ID: 29704487 [TBL] [Abstract][Full Text] [Related]
44. [Premature labor and fetal fibronectin in cervical and vaginal secretions]. Lorenz-Eberhardt G; Weiss PA; Haas J; Pürstner P; Adelwöhrer NE Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):414-6. PubMed ID: 7926575 [TBL] [Abstract][Full Text] [Related]
45. [Preliminary results of fetal fibronectin testing in twin pregnancies]. Markova I; Nikolov A; Markov P Akush Ginekol (Sofiia); 2014; 53(6):4-8. PubMed ID: 25993735 [TBL] [Abstract][Full Text] [Related]
46. [Predictive value of combined fibronectin and ultrasound cervical assessment in twin pregnancies]. Deplagne C; Maurice-Tison S; Coatleven F; Vandenbossche F; Horovitz J Gynecol Obstet Fertil; 2013 May; 41(5):289-96. PubMed ID: 22521981 [TBL] [Abstract][Full Text] [Related]
47. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial). Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290 [TBL] [Abstract][Full Text] [Related]
48. Prediction of preterm delivery among women with threatened preterm labor. Eroglu D; Yanik F; Oktem M; Zeyneloglu HB; Kuscu E Gynecol Obstet Invest; 2007; 64(2):109-16. PubMed ID: 17339775 [TBL] [Abstract][Full Text] [Related]
49. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Leitich H; Egarter C; Kaider A; Hohlagschwandtner M; Berghammer P; Husslein P Am J Obstet Gynecol; 1999 May; 180(5):1169-76. PubMed ID: 10329873 [TBL] [Abstract][Full Text] [Related]
50. Use of fetal fibronectin testing in women transferred for threatened preterm labour in remote far north Queensland. Downing SG; Wright R; Marquardt T; Callander E Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):403-407. PubMed ID: 30175874 [TBL] [Abstract][Full Text] [Related]
51. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Rizzo G; Capponi A; Arduini D; Lorido C; Romanini C Am J Obstet Gynecol; 1996 Nov; 175(5):1146-51. PubMed ID: 8942480 [TBL] [Abstract][Full Text] [Related]
52. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. Honest H; Bachmann LM; Gupta JK; Kleijnen J; Khan KS BMJ; 2002 Aug; 325(7359):301. PubMed ID: 12169504 [TBL] [Abstract][Full Text] [Related]
54. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Morrison JC; Naef RW; Botti JJ; Katz M; Belluomini JM; McLaughlin BN Obstet Gynecol; 1996 May; 87(5 Pt 1):649-55. PubMed ID: 8677061 [TBL] [Abstract][Full Text] [Related]
55. Outcomes and predictive tests from a dedicated specialist clinic for women at high risk of preterm labour: A ten year audit. Hughes K; Sim S; Roman A; Michalak K; Kane S; Sheehan P Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):405-411. PubMed ID: 28349516 [TBL] [Abstract][Full Text] [Related]
56. Improved management in threatened preterm labour with rapid fetal fibronectin testing. Parry E; Singh TG; Dow D; Noovao F Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480 [TBL] [Abstract][Full Text] [Related]
58. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Gomez R; Romero R; Medina L; Nien JK; Chaiworapongsa T; Carstens M; González R; Espinoza J; Iams JD; Edwin S; Rojas I Am J Obstet Gynecol; 2005 Feb; 192(2):350-9. PubMed ID: 15695971 [TBL] [Abstract][Full Text] [Related]
59. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774 [TBL] [Abstract][Full Text] [Related]